Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,728,506 papers from all fields of science
Search
Sign In
Create Free Account
NK 313
Known as:
NK313
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
liblomycin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trial
Takashi Yoshida
,
M. Ogawa
,
+7 authors
T. Matsuda
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 25205801
SummaryLiblomycin (NK313) is a bleomycin analog that has proved to be associated with less pulmonary toxicity and with more…
Expand
1992
1992
Optimal administration schedules of the newly synthesized platinum analog nk121 and bleomycin analog nk313 in nude mice with squamous cell carcinoma
H. Kanazawa
,
Hideki Yokoe
,
Kikuo Takahashi
,
Ken-ichi Sato
Head and Neck
1992
Corpus ID: 21858368
To determine the optimal administration schedules of the newly synthesized, less nephrotoxic platinum analog NK121 and less…
Expand
1991
1991
Cell killing mode of liblomycin (NK313), a novel dose-survival relationship different from bleomycins.
A. Kuramochi-Motegi
,
H. Kuramochi
,
K. Takahashi
,
T. Takeuchi
Journal of antibiotics (Tokyo. )
1991
Corpus ID: 42051272
Liblomycin (NK313) is a novel derivative of bleomycin (BLM) and peplomycin (PEP). The cell kill kinetics of NK313 on rat ascites…
Expand
1991
1991
[Antitumor effects of newly synthesized analogues of platinum (NK121) and bleomycin (NK313) in nude mice implanted human tumor].
H. Yokoe
,
H. Kanazawa
,
K. Takahashi
,
K. Sato
Gan to kagaku ryoho. Cancer & chemotherapy
1991
Corpus ID: 36472203
In order to exploit the optimal administration schedules of newly synthesized analogues of cisplatin (NK121) and bleomycin (NK313…
Expand
1990
1990
ヌードマウス可移植性悪性黒色腫 (SK-14株) に対するLiblomycin (NK313) , Peplomycin (PEP) の抗腫瘍効果
輝夫 小松
,
勉 小出
,
和之 石原
1990
Corpus ID: 99256366
ヌードマウス可移植性ヒト悪性黒色腫 (SK-14株) に対するLiblomycin (NK313) とPeplomycin (PEP) の単独投与した成績を比較検討した。その結果, NK313およびPEP…
Expand
Highly Cited
1989
Highly Cited
1989
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Y. Ohe
,
K. Nakagawa
,
+7 authors
N. Saijo
Cancer Research
1989
Corpus ID: 37988352
A new model to predict antitumor activity of new analogues was developed, and the cross-resistance against cisplatin (CDDP) and…
Expand
1989
1989
A NOVEL BLEOMYCIN-INACTIVATING ENZYME PRESENT IN LYSOSOMES : METABOLISM OF NK313
H. Takayama
,
Y. Nakagawa
1989
Corpus ID: 83404362
1988
1988
DNA cleavage activity of liblomycin (NK313), a novel analog of bleomycin.
H. Kuramochi
,
A. Motegi
,
K. Takahashi
,
T. Takeuchi
Journal of antibiotics (Tokyo. )
1988
Corpus ID: 7017962
Liblomycin (NK313), a novel analog of bleomycin and peplomycin (PEP), produced acid soluble DNA, base propenals and nucleo bases…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE